Clinical Trials Browser

Phase 3 × Triple Negative Breast Neoplasms × niraparib × Clear all

NCT04915755 2025-07-16

ZEST

Phase 3 Active not recruiting

40 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms